Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies

Autoimmunity

Volumn 41, Issue 6, 2008, Pages 442-453

  Mascaro Blanco, Adita ^a   Alvarez, Kathy ^a   Yu, Xichun ^b   Lindenfeld, JoAnn ^c   Olansky, Leann ^b,d   Lyons, Timothy ^b   Duvall, David ^a   Heuser, Janet S ^a   Gosmanova, Albina ^b   Rubenstein, Carl J ^b   Cooper, Leslie T ^e   Kem, David C ^b,f   Cunningham, Madeleine W ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e MAYO CLINIC   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Autoimmunity; Beta adrenergic receptor; Cardiomyopathy; Myocarditis; Myosin

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BOVINE SERUM ALBUMIN; CARDIAC MYOSIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; MYOSIN ANTIBODY; PROPRANOLOL;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; CARDIOMYOPATHY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENZYME ACTIVITY; EPITOPE MAPPING; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MYOCARDITIS; NONHUMAN; RAT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; AUTOANTIBODIES; CARDIAC MYOSINS; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CROSS REACTIONS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EPITOPES; HUMANS; IMMUNOGLOBULIN G; MOLECULAR SEQUENCE DATA; MYOCARDITIS; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA-2;

EID: 51849145182     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802031579     Document Type: Article

References (66)

1. Caforio, ALP, Goldman, JH, Haven, AJ, Baig, KM and McKenna, WJ (1996) Evidence for autoimmunity to myosin and other heart-specific autoantigens in patients with dilated cardiomyopathy and their relatives. Int J Cardiol, 54, pp. 157-163.
2. Brown, CA and O'Connell, JB (1995) Myocarditis and idiopathic dilated cardiomyopathy. Am J Med, 99, pp. 309-314.
3. Felker, GM, Hu, W., Hare, JM, Hruban, RH, Baughman, KI and Kasper, EK (1999) The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1278 patients. Medicine, 78, pp. 270-283.
4. Aretz, HT (1987) Myocarditis: The Dallas criteria. Hum Pathol, 18, pp. 619-624.
5. Aretz, HT, Billingham, ME, Edwards, WD, Factor, SM, Fallon, JT Fenoglio Jr, JJ et al. (1987) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol, 1, pp. 3-14.
6. Maisch, B., Deeg, P., Liebau, G. and Kochsiek, K. (1983) Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol, 52, pp. 1072-1078.
7. Maisch, B., Trostel-Soeder, R., Stechemesser, E., Berg, PA and Kochsiek, K. (1982) Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol, 48, pp. 533-545.
8. Woodruff, JF (1980) Viral myocarditis - a review. Am J Pathol, 101, pp. 425-466.
9. Towbin, JA, Bowles, KR and Bowles, NE (1999) Etiologies of cardiomyopathy and heart failure. Nat Med, 5, pp. 266-267.
10. Huber, SA, Job, LP and Woodruff, JF (1980) Lysis of infected myofibers by coxsackievirus B3 immune lymphocytes. Am J Pathol, 98, pp. 681-694.
11. Cooper Jr, LT (2000) Giant cell myocarditis: Diagnosis and treatment. Herz, 25, pp. 291-298.
12. Cooper Jr., LT, Berry, GJ and Shabetai, R. (1997) Idiopathic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med, 336, pp. 1860-1866.
13. Fairweather, D., Frisancho-Kiss, S., Yusung, SA, Barrett, MA, Davis, SE Gatewood, SJ et al. (2004) Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am J Pathol, 165, pp. 1883-1894.
14. Fairweather, D., Frisancho-Kiss, S., Yusung, SA, Barrett, MA, Davis, SE Steele, RA et al. (2005) IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J Immunol, 174, pp. 261-269.
15. Rangachari, M., Mauermann, N., Marty, RR, Dirnhofer, S., Kurrer, MO Komnenovic, V. et al. (2006) T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J Exp Med, 203, pp. 2009-2019.
16. Li, Y., Heuser, JS, Cunningham, LC, Kosanke, SD and Cunningham, MW (2006) Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol, 177, pp. 8234-8240.
17. 2+ current in isolated cardiac myocytes. Am J Physiol, 255, pp. H960-H964.
18. Schultheiss, HP, Schulze, K., Schauer, R., Witzenbichler, B. and Strauer, BE (1995) Antibody-mediated imbalance of myocardial energy metabolism. A causal factor of cardiac failure?. Circ Res, 76, pp. 64-72.
19. Galvin, JE, Hemric, ME, Kosanke, SD, Factor, SM, Quinn, A. and Cunningham, MW (2002) Induction of myocarditis and valvulitis in Lewis rat by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am J Pathol, 160, pp. 297-306.
20. Kodama, M., Matsumoto, U., Fujiwara, M., Masani, F., Izumi, T. and Shibata, A. (1990) A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol, 57, pp. 250-262.
21. Li, Y., Heuser, JS, Kosanke, SD, Hemric, ME and Cunningham, MW (2004) Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J Immunol, 172, pp. 3225-3234.
22. Neu, N., Rose, NR, Beisel, KW, Herskowitz, A., Gurri-Glass, G. and Craig, SW (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol, 139, pp. 3630-3636.
23. Kuan, AP, Chamberlain, W., Malkeil, S., Lieu, HD, Factor, SM Diamond, B. et al. (1999) Genetic control of autoimmune myocarditis mediated by myosin-specific antibodies. Immunogenetics, 49, pp. 595-596.
24. Kuan, AP, Zuckier, L., Liao, L., Factor, SM and Diamond, B. (2000) Immunoglobulin isotype determines pathogenicity in antibody-mediated myocarditis in naive mice. Circ Res, 86, pp. 281-285.
25. Liao, L., Sindhwani, R., Rojkind, M., Factor, S., Leinwand, L. and Diamond, B. (1995) Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med, 181, pp. 1123-1131.
26. Neumann, DA, Lane, JR, Wulff, SM, Allen, GS, LaFond-Walker, A. Herskowitz, A. et al. (1992) In vivo deposition of myosin-specific autoantibodies in the hearts of mice with experimental autoimmune myocarditis. J Immunol, 148, pp. 3806-3813.
27. Caforio, AL, Mahon, NJ and McKenna, WJ (2001) Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity, 34, pp. 199-204.
28. Lauer, B., Schannwell, M., Kuhl, U., Strauer, BE and Schultheiss, HP (2001) Antimyosin autoantibodies are associated with deterioration of systolic and diastolic left ventricular function in patients with chronic myocarditis. J Am Coll Cardiol, 37, pp. 1106-1110.
29. Maisch, B., Deeg, P., Liebau, G. and Kochsiek, K. (1983) Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol, 52, pp. 1072-1078.
30. Neumann, DA, Burek, CL, Baughman, KL, Rose, NR and Herskowitz, A. (1990) Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy. J Am Coll Cardiol, 16, pp. 839-846.
31. Felix, SB, Staudt, A. and Friedrich, GB (2001) Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy. Autoimmunity, 34, pp. 211-215.
32. Rose, NR (2006) The significance of autoimmunity in myocarditis. Ernst Schering Res Found Workshop, 55, pp. 141-154.
33. Chow, LH, Yuling, Y., Linder, J. and McManus, BM (1989) Phenotypic analysis of infiltrating cells in human myocarditis. Arch Pathol Lab Med, 113, pp. 1357-1362.
34. Cunningham, MW, Antone, SM, Gulizia, JM, McManus, BA and Gauntt, CJ (1993) Alpha-helical coiled-coil molecules: A role in autoimmunity against the heart. Clin Immunol Immunopathol, 68, pp. 129-134.
35. Cunningham, MW, Antone, SM, Gulizia, JM, McManus, BM, Fischetti, VA and Gauntt, CJ (1992) Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci USA, 89, pp. 1320-1324.
36. Liao, L., Sindhwani, R., Rojkind, M., Factor, S., Leinwand, L. and Diamond, B. (1995) Antibody-mediated autoimmune myocarditis depends on genetically determined target organ sensitivity. J Exp Med, 187, pp. 1123-1131.
37. Antone, SM, Adderson, EE, Mertens, NMJ and Cunningham, MW (1997) Molecular analysis of V gene sequences encoding cytotoxic anti-streptococcal/anti-myosin monoclonal antibody 36.2.2 that recognizes the heart cell surface protein laminin. J Immunol, 159, pp. 5422-5430.
38. Tobacman, LS and Adelstein, RS (1984) Enzymatic comparisons between light chain isozymes of human cardiac myosin subfragment-1. J Biol Chem, 259, pp. 11226-11230.
39. Galvin, JE, Hemric, ME, Ward, K. and Cunningham, MW (2000) Cytotoxic monoclonal antibody from rheumatic carditis reacts with human endothelium: Implications in rheumatic heart disease. J Clin Invest, 106, pp. 217-224.
40. Jaenicke, T., Diederich, KW, Haas, W., Scheich, J., Lichter, P. Pfordt, M. et al. (1990) Complete sequence of human b myosin. Genomics, 8, pp. 194-207.
41. Cunningham, MW, Meissner, HC, Heuser, J. and Leung, DYM (1999) Anti-human cardiac myosin autoantibodies in Kawasaki syndrome. J Immunol, 163, pp. 1060-1065.
42. Cunningham, MW and Swerlick, RA (1986) Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity. J Exp Med, 164, pp. 998-1012.
43. Laemmli, UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 277, p. 680.
44. Caforio, AL, Goldman, JH, Baig, MK, Haven, AJ, Dalla Libera, L Keeling, PJ et al. (1997) Cardiac autoantibodies in dilated cardiomyopathy become undetectable with disease progression. Heart, 77, pp. 62-67.
45. Caforio, AL, Goldman, JH, Haven, AJ, Baig, KM, Libera, LD and McKenna, WJ (1997) Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis. The myocarditis treatment trial investigators. Eur Heart J, 18, pp. 270-275.
46. Caforio, AL, Grazzini, M., Mann, JM, Keeling, PJ, Bottazzo, GF McKenna, WJ et al. (1992) Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation, 85, pp. 1734-1742.
47. Caforio, AL, Mahon, NG and McKenna, WJ (2006) Clinical implications of anti-cardiac immunity in dilated cardiomyopathy. Ernst Schering Res Found Workshop, pp. 169-193.
48. Caforio, AL, Mahon, NJ and McKenna, WJ (2001) Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity, 34, pp. 199-204.
49. Caforio, AL, Mahon, NJ, Tona, F. and McKenna, WJ (2002) Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: Pathogenetic and clinical significance. Eur J Heart Fail, 4, pp. 411-417.
50. Kodama, M., Hanawa, H., Zhang, S., Saeki, M., Koyama, S. Hosono, H. et al. (1993) FK506 therapy of experimental autoimmune myocarditis after onset of the disease. Am Heart J, 126, pp. 1385-1392.
51. Kodama, M., Hanawa, H., Saeki, M., Hosono, H., Inomata, T. Suzuki, K. et al. (1994) Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res, 75, pp. 278-284.
52. Kodama, M., Matsumoto, Y., Fujiwara, M., Massani, M., Izumi, T. and Shibota, A. (1991) A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol, 57, pp. 250-262.
53. Neu, N., Rose, NR, Beisel, KW, Herskowitz, A., Gurri-Glass, G. and Craig, SW (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol, 139, pp. 3630-3636.
54. Smith, SC and Allen, PM (1991) Myosin-induced acute myocarditis is a T cell mediated disease. J Immunol, 147, pp. 2141-2147.
55. Galvin, JE, Hemric, ME, Kosanke, SD, Factor, SM, Quinn, A. and Cunningham, MW (2001) Induction of myocarditis and valvulitis in Lewis rats by different epitopes of cardiac myosin and its implications in rheumatic carditis. Am J Pathol, 160, pp. 297-306.
56. Liao, L., Sindhwani, R., Leinwand, L., Diamond, B. and Factor, S. (1993) Cardiac alpha-myosin heavy chains differ in their induction of myocarditis: Identification of pathogenic epitopes. J Clin Invest, 92, p. 2877.
57. Cunningham, MW, McCormack, JM, Fenderson, PG, Ho, MK, Beachey, EH and Dale, JB (1989) Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol, 143, pp. 2677-2683.
58. Cunningham, MW (2000) Pathogenesis of group A streptococcal infections. Clin Microbiol Rev, 13, pp. 470-511.
59. Cunningham, MW, McCormack, JM, Talaber, LR, Harley, JB, Ayoub, EM Muneer, RS et al. (1988) Human monoclonal antibodies reactive with antigens of the group A streptococcus and human heart. J Immunol, 141, pp. 2760-2766.
60. Rose, NR (1998) The role of infection in the pathogenesis of autoimmune disease. Semin Immunol, 10, pp. 5-13.
61. Kirvan, CA, Swedo, SE, Heuser, S. and Cunningham, MW (2003) Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med, 9, pp. 914-920.
62. Rockman, HA, Koch, WJ and Lefkowitz, RJ (2002) Seven-transmembrane-spanning receptors and heart function. Nature, 415, pp. 206-212.
63. Freedman, NJ and Lefkowitz, RJ (2004) Anti-beta-1-adrenergic receptor antibodies and heart failure: Causation, not just correlation. J Clin Invest, 113, pp. 1379-1382.
64. Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, CE Ertl, G. et al. (2004) Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest, 113, pp. 1419-1429.
65. Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, CE Ertl, G. et al. (2004) Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest, 113, pp. 1419-1429.
66. Arbuckle, MR, McClain, MT, Rubertone, MV, Scofield, RH, Dennis, GJ James, JA et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med, 349, pp. 1526-1533.